| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 5873511
[patent_doc_number] => 20020048599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-25
[patent_title] => 'Method for increasing tissue perfusion by co-administration of an agent that increases cGMP synthesis and an agent that inhibits cGMP degradation'
[patent_app_type] => new
[patent_app_number] => 09/981335
[patent_app_country] => US
[patent_app_date] => 2001-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 770
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20020048599.pdf
[firstpage_image] =>[orig_patent_app_number] => 09981335
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/981335 | Method for increasing tissue perfusion by co-administration of an agent that increases cGMP synthesis and an agent that inhibits cGMP degradation | Oct 15, 2001 | Abandoned |
Array
(
[id] => 1425768
[patent_doc_number] => 06503939
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-01-07
[patent_title] => 'Combination regimens using 3,3-substituted indoline derivatives'
[patent_app_type] => B2
[patent_app_number] => 09/977790
[patent_app_country] => US
[patent_app_date] => 2001-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11173
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 861
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/503/06503939.pdf
[firstpage_image] =>[orig_patent_app_number] => 09977790
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/977790 | Combination regimens using 3,3-substituted indoline derivatives | Oct 14, 2001 | Issued |
| 09/972992 | Anti-inflammatory complex containing flaxseed oil | Oct 9, 2001 | Abandoned |
Array
(
[id] => 6512209
[patent_doc_number] => 20020025981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-28
[patent_title] => 'Combination therapy'
[patent_app_type] => new
[patent_app_number] => 09/975765
[patent_app_country] => US
[patent_app_date] => 2001-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13140
[patent_no_of_claims] => 106
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20020025981.pdf
[firstpage_image] =>[orig_patent_app_number] => 09975765
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/975765 | Combination therapy | Oct 9, 2001 | Abandoned |
Array
(
[id] => 6817403
[patent_doc_number] => 20030068361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => 'Liposome-encapsulated insulin formulations'
[patent_app_type] => new
[patent_app_number] => 09/975752
[patent_app_country] => US
[patent_app_date] => 2001-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12505
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20030068361.pdf
[firstpage_image] =>[orig_patent_app_number] => 09975752
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/975752 | Liposome-encapsulated insulin formulations | Oct 8, 2001 | Abandoned |
Array
(
[id] => 1384682
[patent_doc_number] => 06552048
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-04-22
[patent_title] => 'Sulfonylcarboxamide derivatives, process for their preparation and their use as pharmaceuticals'
[patent_app_type] => B2
[patent_app_number] => 09/963380
[patent_app_country] => US
[patent_app_date] => 2001-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9818
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 635
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/552/06552048.pdf
[firstpage_image] =>[orig_patent_app_number] => 09963380
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/963380 | Sulfonylcarboxamide derivatives, process for their preparation and their use as pharmaceuticals | Sep 26, 2001 | Issued |
Array
(
[id] => 6778203
[patent_doc_number] => 20030049284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Method of increasing the solubility of alphahydrocarboxilic salts, and products obtained by the method'
[patent_app_type] => new
[patent_app_number] => 09/946167
[patent_app_country] => US
[patent_app_date] => 2001-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3669
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20030049284.pdf
[firstpage_image] =>[orig_patent_app_number] => 09946167
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/946167 | Method of increasing the solubility of alphahydrocarboxilic salts, and products obtained by the method | Sep 4, 2001 | Abandoned |
| 09/913438 | Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding | Aug 13, 2001 | Abandoned |
Array
(
[id] => 6064174
[patent_doc_number] => 20020032182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-14
[patent_title] => 'Method of treating hypersomnia sleep disturbance or insomnia sleep disturbance that is secondary to another condition'
[patent_app_type] => new
[patent_app_number] => 09/918956
[patent_app_country] => US
[patent_app_date] => 2001-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7179
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20020032182.pdf
[firstpage_image] =>[orig_patent_app_number] => 09918956
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/918956 | Method of treating hypersomnia sleep disturbance or insomnia sleep disturbance that is secondary to another condition | Jul 30, 2001 | Abandoned |
Array
(
[id] => 6097199
[patent_doc_number] => 20020052414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-02
[patent_title] => 'Use, in cosmetic preparations, of prostaglandin EP-2 and/or EP-4 receptor antagonists to attenuate, reduce or stop the growth of head hair and other hairs'
[patent_app_type] => new
[patent_app_number] => 09/917211
[patent_app_country] => US
[patent_app_date] => 2001-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2605
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20020052414.pdf
[firstpage_image] =>[orig_patent_app_number] => 09917211
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/917211 | Use, in cosmetic preparations, of prostaglandin EP-2 and/or EP-4 receptor antagonists to attenuate, reduce or stop the growth of head hair and other hairs | Jul 29, 2001 | Pending |
| 09/868798 | Deodorizing cosmetic agents | Jul 29, 2001 | Abandoned |
Array
(
[id] => 6688895
[patent_doc_number] => 20030032620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Low molecular weight chondroitin sulphate compound having cosmetic activity'
[patent_app_type] => new
[patent_app_number] => 09/912267
[patent_app_country] => US
[patent_app_date] => 2001-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3066
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20030032620.pdf
[firstpage_image] =>[orig_patent_app_number] => 09912267
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/912267 | Low molecular weight chondroitin sulphate compound having cosmetic activity | Jul 24, 2001 | Abandoned |
Array
(
[id] => 1560432
[patent_doc_number] => 06436988
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-20
[patent_title] => 'Use of 3-(2,4,6-trimethylphenyl)-4-neopentylcarbonyloxy-5,5- tetramethylene-3-dihydrofuran-2-one for controlling the white fly'
[patent_app_type] => B1
[patent_app_number] => 09/889470
[patent_app_country] => US
[patent_app_date] => 2001-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1148
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/436/06436988.pdf
[firstpage_image] =>[orig_patent_app_number] => 09889470
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/889470 | Use of 3-(2,4,6-trimethylphenyl)-4-neopentylcarbonyloxy-5,5- tetramethylene-3-dihydrofuran-2-one for controlling the white fly | Jul 16, 2001 | Issued |
Array
(
[id] => 1363521
[patent_doc_number] => 06569864
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-27
[patent_title] => 'Pharmaceutical agents containing acyclovir, fusaric acid and derivatives thereof'
[patent_app_type] => B1
[patent_app_number] => 09/903337
[patent_app_country] => US
[patent_app_date] => 2001-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6527
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/569/06569864.pdf
[firstpage_image] =>[orig_patent_app_number] => 09903337
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/903337 | Pharmaceutical agents containing acyclovir, fusaric acid and derivatives thereof | Jul 10, 2001 | Issued |
Array
(
[id] => 5815207
[patent_doc_number] => 20020040018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-04
[patent_title] => 'Subtype selective melatonergics'
[patent_app_type] => new
[patent_app_number] => 09/886609
[patent_app_country] => US
[patent_app_date] => 2001-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7870
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20020040018.pdf
[firstpage_image] =>[orig_patent_app_number] => 09886609
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/886609 | Subtype selective melatonergics | Jun 21, 2001 | Abandoned |
Array
(
[id] => 6648740
[patent_doc_number] => 20030007961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-09
[patent_title] => 'Orthomolecular vitamin E derivatives'
[patent_app_type] => new
[patent_app_number] => 09/886472
[patent_app_country] => US
[patent_app_date] => 2001-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16536
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0007/20030007961.pdf
[firstpage_image] =>[orig_patent_app_number] => 09886472
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/886472 | Orthomolecular vitamin E derivatives | Jun 21, 2001 | Abandoned |
| 09/876875 | Compositions and methods for treating aphthous ulcers, gingivitis and herpes simplex | Jun 6, 2001 | Abandoned |
Array
(
[id] => 6653314
[patent_doc_number] => 20030008878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-09
[patent_title] => 'Benzimidazoles that are useful in treating sexual dysfunction'
[patent_app_type] => new
[patent_app_number] => 09/874484
[patent_app_country] => US
[patent_app_date] => 2001-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20723
[patent_no_of_claims] => 96
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20030008878.pdf
[firstpage_image] =>[orig_patent_app_number] => 09874484
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/874484 | Benzimidazoles that are useful in treating sexual dysfunction | Jun 4, 2001 | Abandoned |
| 09/856827 | Medicinal compositions for periodic administration | May 24, 2001 | Abandoned |
Array
(
[id] => 6000615
[patent_doc_number] => 20020028794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-07
[patent_title] => 'Megestrol acetate suspension'
[patent_app_type] => new
[patent_app_number] => 09/864841
[patent_app_country] => US
[patent_app_date] => 2001-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4505
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20020028794.pdf
[firstpage_image] =>[orig_patent_app_number] => 09864841
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/864841 | Megestrol acetate suspension | May 23, 2001 | Abandoned |
